Effectiveness of Magnolol, a Lignan from Magnolia Bark, in Diabetes, Its Complications and Comorbidities-A Review

被引:28
作者
Szalabska-Rapala, Katarzyna [1 ]
Borymska, Weronika [2 ]
Kaczmarczyk-Sedlak, Ilona [2 ]
机构
[1] Med Univ Silesia, Fac Pharmaceut Sci Sosnowiec, Dept Pharmacognosy & Phytochem, Doctoral Sch,Discipline Pharmaceut Sci, Jagiellonska 4, PL-41200 Sosnowiec, Poland
[2] Med Univ Silesia, Fac Pharmaceut Sci Sosnowiec, Dept Pharmacognosy & Phytochem, Jagiellonska 4, PL-41200 Sosnowiec, Poland
关键词
magnolol; lignan; diabetes; diabetic complications; plant-derived polyphenols; antidiabetic potential; HIGH-FAT DIET; PANCREATIC BETA-CELLS; GROWTH-FACTOR-BETA; PIGMENT EPITHELIAL-CELLS; GLYCATION END-PRODUCTS; OXIDATIVE STRESS; INSULIN-RESISTANCE; PERIODONTAL-DISEASE; METABOLIC SYNDROME; KIOM-4; PROTECTS;
D O I
10.3390/ijms221810050
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diabetes mellitus is a chronic metabolic disease characterized by disturbances in carbohydrate, protein, and lipid metabolism, often accompanied by oxidative stress. Diabetes treatment is a complicated process in which, in addition to the standard pharmacological action, it is necessary to append a comprehensive approach. Introducing the aspect of non-pharmacological treatment of diabetes allows one to alleviate its many adverse complications. Therefore, it seems important to look for substances that, when included in the daily diet, can improve diabetic parameters. Magnolol, a polyphenolic compound found in magnolia bark, is known for its health-promoting activities and multidirectional beneficial effects on the body. Accordingly, the goal of this review is to systematize the available scientific literature on its beneficial effects on type 2 diabetes and its complications. Taking the above into consideration, the article collects data on the favorable effects of magnolol on parameters related to glycemia, lipid metabolism, or oxidative stress in the course of diabetes. After careful analysis of many scientific articles, it can be concluded that this lignan is a promising agent supporting the conventional therapies with antidiabetic drugs in order to manage diabetes and diabetes-related diseases.
引用
收藏
页数:23
相关论文
共 149 条
[31]  
Gazioglu SB, 2015, INT J CLIN EXP PATHO, V8, P15919
[32]   Effects of periodontal disease on glycemic control, complications, and incidence of diabetes mellitus [J].
Genco, Robert J. ;
Graziani, Filippo ;
Hasturk, Hatice .
PERIODONTOLOGY 2000, 2020, 83 (01) :59-65
[33]   The Transforming Growth Factor-β Pathway Is a Common Target of Drugs That Prevent Experimental Diabetic Retinopathy [J].
Gerhardinger, Chiara ;
Dagher, Zeina ;
Sebastiani, Paola ;
Park, Yong Seek ;
Lorenzi, Mara .
DIABETES, 2009, 58 (07) :1659-1667
[34]   Adipogenesis and metabolic health [J].
Ghaben, Alexandra L. ;
Scherer, Philipp E. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2019, 20 (04) :242-258
[35]  
Glintborg D., 2020, CURR OPIN ENDOC META, V12, P33, DOI [10.1016/j.coemr.2020.02.014, DOI 10.1016/J.COEMR.2020.02.014]
[36]   Diabetic Nephropathy: Perspective on Novel Molecular Mechanisms [J].
Gnudi, Luigi ;
Coward, Richard J. M. ;
Long, David A. .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2016, 27 (11) :820-830
[37]   Metabolic syndrome update [J].
Grundy, Scott M. .
TRENDS IN CARDIOVASCULAR MEDICINE, 2016, 26 (04) :364-373
[38]   Antioxidant activity and protection of pancreatic ß-cells by embelin in streptozotocin-induced diabetes [J].
Gupta, Rajnish ;
Sharma, Anil K. ;
Sharma, Mahesh C. ;
Gupta, Radhey S. .
JOURNAL OF DIABETES, 2012, 4 (03) :248-256
[39]   Role of gut microbiota in type 2 diabetes pathophysiology [J].
Gurung, Manoj ;
Li, Zhipeng ;
You, Hannah ;
Rodrigues, Richard ;
Jump, Donald B. ;
Morgun, Andrey ;
Shulzhenko, Natalia .
EBIOMEDICINE, 2020, 51
[40]   Myocardial fibrosis: biomedical research from bench to bedside [J].
Gyoengyoesi, Mariann ;
Winkler, Johannes ;
Ramos, Isbaal ;
Quoc-Tuan Do ;
Firat, Huseyin ;
McDonald, Kenneth ;
Gonzalez, Arantxa ;
Thum, Thomas ;
Diez, Javier ;
Jaisser, Frederic ;
Pizard, Anne ;
Zannad, Faiez .
EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (02) :177-191